Evidence for a naF-resistant association between mRNA and ribosomes in rabbit reticulocytes.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 6057660)

Published in Biochim Biophys Acta on March 29, 1967

Authors

B Lebleu, G Huez, A Burny, G Marbaix

Articles by these authors

Rabbit haemoglobin synthesis in frog cells: the translation of reticulocyte 9 s RNA in frog oocytes. J Mol Biol (1971) 6.97

Use of frog eggs and oocytes for the study of messenger RNA and its translation in living cells. Nature (1971) 6.97

Purification of the DNA polymerase of avian myeloblastosis virus. Biochim Biophys Acta (1971) 6.64

A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem (1997) 6.52

Characterization of the products of DNA-directed DNA polymerases in oncogenic RNA viruses. Nature (1970) 5.23

DNA-directed DNA polymerase activity in oncogenic RNA viruses. Nature (1970) 4.81

Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science (1986) 4.04

Synthetic DNA-RNA hybrids and RNA-RNA duplexes as templates for the polymerases of the oncogenic RNA viruses. Nature (1970) 3.98

Translational blockade imposed by cytokine-derived UA-rich sequences. Science (1989) 3.68

A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med (2000) 3.54

The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J (1989) 3.50

Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA. J Biol Chem (1999) 3.43

The 3' untranslated region of the human interferon-beta mRNA has an inhibitory effect on translation. Proc Natl Acad Sci U S A (1987) 3.37

Interferon, double-stranded RNA, and protein phosphorylation. Proc Natl Acad Sci U S A (1976) 3.24

HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J (1999) 3.10

Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc Natl Acad Sci U S A (1987) 3.00

The gag and pol genes of bovine leukemia virus: nucleotide sequence and analysis. Virology (1985) 2.53

Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc Natl Acad Sci U S A (1985) 2.35

[Isolation of messenger RNA from rabbit reticulocytes]. Biochim Biophys Acta (1965) 2.25

Intracellular distribution of microinjected antisense oligonucleotides. Proc Natl Acad Sci U S A (1991) 2.22

AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors. Biochem Soc Trans (2002) 2.18

Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J Biol Chem (1997) 2.17

The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature (1988) 2.16

cDNA cloning and assignment to chromosome 21 of IFI-78K gene, the human equivalent of murine Mx gene. Somat Cell Mol Genet (1988) 2.13

Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12

Role of the polyadenylate segment in the translation of globin messenger RNA in Xenopus oocytes. Proc Natl Acad Sci U S A (1974) 2.05

Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc Natl Acad Sci U S A (1982) 2.02

Bovine leukemia virus: an exogenous RNA oncogenic virus. Proc Natl Acad Sci U S A (1976) 2.01

Correlation between the antiviral effect of interferon treatment and the inhibition of in vitro mRNA translation in noninfected L cells. J Virol (1973) 2.00

The nucleotide sequence of the env gene and post-env region of bovine leukemia virus. Virology (1984) 1.98

Message stability in injected frog oocytes: long life of mammalian alpha and beta globin messages. J Mol Biol (1973) 1.91

Interactive effects of the tumor necrosis factor promoter and 3'-untranslated regions. J Immunol (1991) 1.89

Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood (1995) 1.75

Interferon, double-stranded RNA and mRNA degradation. Nature (1976) 1.70

In vivo infection of sheep by bovine leukemia virus mutants. J Virol (1993) 1.69

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A (1998) 1.68

DNA polymerase activities in varions of visna virus, a causative agent of a "slow" neurological disease. Proc Natl Acad Sci U S A (1971) 1.67

Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells. Science (1985) 1.67

TAT peptide internalization: seeking the mechanism of entry. Curr Protein Pept Sci (2003) 1.66

Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51. J Virol Methods (1989) 1.66

Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol (1999) 1.65

Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells. Nucleic Acids Res (1986) 1.62

Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A (1980) 1.61

Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation. Anticancer Drug Des (1993) 1.61

Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway. J Biol Chem (1995) 1.60

Translation of bovine leukemia virus virion RNAs in heterologous protein-synthesizing systems. J Virol (1979) 1.60

Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species. J Virol (1981) 1.58

Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor. J Virol (1993) 1.58

C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci U S A (1998) 1.57

Discrimination between messenger ribonucleic acids by a mammalian translation initiation factor. Proc Natl Acad Sci U S A (1973) 1.57

An immunophilin that binds M(r) 90,000 heat shock protein: main structural features of a mammalian p59 protein. Proc Natl Acad Sci U S A (1992) 1.56

Characterization of the messenger ribonucleoprotein released from reticulocyte polyribosomes by EDTA treatment. Eur J Biochem (1971) 1.56

Genomic integration of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk Res (1980) 1.53

alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition. Nucleic Acids Res (1987) 1.53

Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. Virology (1993) 1.52

Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes. Proc Natl Acad Sci U S A (1975) 1.51

Cell-penetrating-peptide-based delivery of oligonucleotides: an overview. Biochem Soc Trans (2007) 1.49

The bovine leukemia virus p34 is a transactivator protein. EMBO J (1987) 1.48

Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J (1990) 1.44

Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci U S A (2000) 1.42

Readenylation of polyadenylate-free globin messenger RNA restores its stability in vivo. Eur J Biochem (1975) 1.40

Bovine leukemia virus, an animal model for the study of intrastrain variability. J Virol (1993) 1.38

Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. J Hum Virol (1999) 1.38

Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA;. Biochem Biophys Res Commun (1976) 1.37

Sequence requirements for premature transcription arrest within the first intron of the mouse c-fos gene. Mol Cell Biol (1991) 1.36

Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J (2008) 1.35

Release of messenger RNA from rabbit reticulocyte polyribosomes at low concentration of divalent cations. Biochim Biophys Acta (1967) 1.35

Translational stability of native and deadenylylated rabbit globin mRNA injected into HeLa cells. Proc Natl Acad Sci U S A (1981) 1.35

Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc Natl Acad Sci U S A (1994) 1.31

Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. J Virol (1989) 1.30

Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol Cell Biol (1998) 1.30

Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Cancer Surv (1987) 1.29

Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. Vaccine (1991) 1.28

The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J Virol (1997) 1.28

Comparative evaluation of seven oligonucleotide analogues as potential antisense agents. J Med Chem (1993) 1.27

Translational capacity of living frog eggs and oocytes, as judged by messenger RNA injection. J Mol Biol (1971) 1.26

A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J Virol (1994) 1.26

Functional stabilisation of HeLa cell histone messenger RNAs injected into Xenopus oocytes by 3'-OH polyadenylation. Nature (1978) 1.26

In vivo transfection of bovine leukemia provirus into sheep. Virology (1992) 1.25

Molecular cloning, full-length sequence and preliminary characterization of a 56-kDa protein induced by human interferons. Eur J Biochem (1986) 1.24

Restriction endonuclease mapping of linear unintegrated proviral DNA of bovine leukemia virus. J Virol (1981) 1.24

Thermosensitive mutations affecting ribonucleic acid polymerases in Saccharomyces cerevisiae. J Bacteriol (1976) 1.24

Humoral antibody response to bovine leukemia virus infection in cattle and sheep. Cancer Res (1979) 1.24

Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Vet Microbiol (1988) 1.23

Integration of bovine leukemia virus DNA in the bovine genome. Proc Natl Acad Sci U S A (1979) 1.23